<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02090790</url>
  </required_header>
  <id_info>
    <org_study_id>2013/400</org_study_id>
    <nct_id>NCT02090790</nct_id>
  </id_info>
  <brief_title>Comparison of Analgesic Consumption Between Perioperative ıv Dexamethasone and Added to Femoral Block</brief_title>
  <official_title>The Compare the Effect of Peroperative Intravenous Single Dose Dexamethasone and the Addition of Dexamethasone to Femoral Nerve Block on Postoperative Analgesic Consumption Anf Patient Comfort in Unilateral Total Knee Arthroplasty Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TC Erciyes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TC Erciyes University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      the aim of this study was to investigate compare the effect of peroperative intravenous
      single dose dexamethasone and the addition of dexamethasone to femoral nerve block on
      postoperative analgesic consumption and patient comfort in unilateral total knee arthroplasty
      patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Total knee arthroplasty leads to severe postoperative pain. for postoperative pain control
      after total knee arthroplasty oral -intramuscular opioids ,patient controlled analgesia
      intravenous or epidural opioids, single -continuous femoral nerve block involving techniques
      are used.

      Dexamethasone is a glucocorticoid of high potency and frequently used
      perioperative.Dexamethasone to the local anaesthetic solution administered trough in femoral
      nerve blocks significantly prolonged the analgesic effect of the local anaesthetics used on
      this blocks.If the analgesic efficacy of systemic treatment with dexamethasone is similar
      with the use of perineural wich is the safest way should be preferred for systemic use.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visual analog scale</measure>
    <time_frame>postoperative 2 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>analgesic consumption</measure>
    <time_frame>postoperative 2 day</time_frame>
    <description>morphine consumption (patient controlled analgesia procedure)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>iv dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>perioperative 2ml 8 mg ıv dexamethasone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>femoral dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>femoral block was performed postoperative 30 ml 0,5 % bupivacaine added 2 ml 8 mg dexamethasone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>serum physiologic</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>iv dexamethasone</intervention_name>
    <description>2 ml 8 mg iv dexamethasone</description>
    <arm_group_label>iv dexamethasone</arm_group_label>
    <other_name>decort</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>femoral dexamethasone</intervention_name>
    <description>2ml 8mg dexamethasone administration added 30 ml 0,5 % bupivacain</description>
    <arm_group_label>femoral dexamethasone</arm_group_label>
    <other_name>dekort</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>serum physiologic</intervention_name>
    <description>2 ml iv serum physiologic</description>
    <arm_group_label>serum physiologic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  between 18-65 age

          -  knee arthroplasty

          -  no known allergies to drugs

          -  ASA 1-2 patients

        Exclusion Criteria:

          -  history of diabetes

          -  history of chronic pain treatment

          -  pregnancy

          -  severe bronchopulmonary disease

          -  systemic opioid and steroid use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ahmet öner, recident</last_name>
    <role>Principal Investigator</role>
    <affiliation>erciyes univercity</affiliation>
  </overall_official>
  <overall_official>
    <last_name>gülen güler, prof</last_name>
    <role>Study Director</role>
    <affiliation>erciyes univercity</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ahmet öner, resident</last_name>
    <phone>+9055059504112</phone>
    <email>dr_ahmetoner@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>gülen güler, prof</last_name>
    <phone>+905327922484</phone>
    <email>gulen@erciyes.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erciyes Univercity Hospital</name>
      <address>
        <city>Kayseri</city>
        <zip>38039</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ahmet öner, resident</last_name>
      <phone>+905059504112</phone>
      <email>dr_ahmetoner@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>gülen güler, prof</last_name>
      <phone>+905327922484</phone>
      <email>gulen@erciyes.edu.tr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2014</study_first_submitted>
  <study_first_submitted_qc>March 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2014</study_first_posted>
  <last_update_submitted>March 20, 2014</last_update_submitted>
  <last_update_submitted_qc>March 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TC Erciyes University</investigator_affiliation>
    <investigator_full_name>ahmet öner</investigator_full_name>
    <investigator_title>resident</investigator_title>
  </responsible_party>
  <keyword>dexamethasone</keyword>
  <keyword>femoral block</keyword>
  <keyword>total knee arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

